Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Reflections of Oxygen Delivery Methods Applied in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) on Blood Gas and Spirometer Measurements

NCT06561464•Ankara Etlik City Hospital

View on ClinicalTrials.gov

Summary

To examine the effects of oxygen therapy methods applied as indicated in COPD acute exacerbations on blood gas results and spirometric measurements.

Detailed Description

Patients requiring non-invasive ventilation will be divided into two groups: one group will receive NIMV in the form of Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP). The other group will receive EzPAP® (a non-invasive positive airway pressure device). For both groups, blood gas results and hand-held spirometer parameters, including Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF), and Forced Expiratory Volume in one second (FEV1), will be evaluated before and after the application.It is aimed to evaluate the effect of COPD noninvasive treatment methods on hospitalization and mortality processes.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with acute exacerbation of COPD,
•Those without a history of trauma,
•Patients who have not undergone any lung surgery previously,
•Patients capable of providing written and verbal consent.

Exclusion Criteria

•Patients without acute exacerbation of COPD,
•Pregnancy, suspected pregnancy,
•Those who have undergone any lung surgery previously,
•Patients with a history of trauma,
•Intubated patients and those not compliant with treatments,
•Patients unable to provide written and verbal consent.

Locations (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)

Key Dates

Start Date

November 1, 2023

Primary Completion Date

April 30, 2024

Completion Date

June 1, 2024

Last Updated

October 1, 2024

Enrollment

100

ACTUAL participants

Conditions

Chronic Obstructive Pulmonary Disease Exacerbation

Interventions

EzPAP®

DEVICE

Non-invasive mechanical ventilation (NIMV)

DEVICE

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

NCT05776654

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease Exacerbation

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions